adagrasib,Pembrolizumab
mirati,merck
['nsclc', 'sclc', 'ca,022,i', 'ca,022,1', 'lung', 'mirati', 'zailab']
#qmportfolio our portfolio company (nasdaq:zlab, sehk:9688)'s partner announced late-breaking #investigational data in first line advanced/metastatic non-small cell lung cancer (#nsclc) at the 2022 immuno-oncology annual congress. 
Founded in 2006, Qiming is a leading China VC firm with $9.4 billion in capital raised. We invest in the T&C and healthcare industries.